Why This Psychedelics Company is Focused on Weight Management
Psychedelics are transforming so many aspects of our everyday lives — from treating mental health conditions to weight management and obesity. Companies like NeonMind Biosciences are at the forefront of this innovation and strongly believe in “mind over matter” while supporting health through its psychedelic drug development program. In this video Q&A, Stockhouse Editorial's Jocelyn Aspa was joined by company CEO Rob Tessarolo to update our investor audience on this intriguing psychedelics play.
Read the Full Story Here
Weekly Update - Top Cannabis News Stories
1 | Top Story: Adastra Labs Holdings Ltd. announces 2021 Annual Financial Results and Corporate Update.
2 | Psyched Wellness Ltd. provides update on Annual General and Special Meeting.
3 | HEXO Corp. announces leadership transition; appoints permanent CEO.
4 | Curaleaf Holdings's Select Brand expands CBD offerings with launch of CBD Bites.
5 | The Flowr Corporation sells Holigen Holdings and completes a $1 million private placement.
Top Cannabis Stocks June 30 to Juy 6, 2022
FULL DISCLOSURE: NeonMind Biosciences, Adastra Labs Holdings Ltd., and Psyched Wellness Ltd. are clients of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.